APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharma Continuous Granulation

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pharma Continuous Granulation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173839150329 December 2025196 pages

Choose your research edition.

Industry ResearchPharma Continuous Granulation Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharma Continuous Granulation Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Pharma Continuous Granulation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharma Continuous Granulation Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharma Continuous Granulation Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Pharma Continuous Granulation market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pharma Continuous Granulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharma Continuous Granulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharma Continuous Granulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pharma Continuous Granulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharma Continuous Granulation include LB Bohle, GEA, LCI, Chansemt, Thermo Fisher Scientific, Syntegon, Senieer, LÖDIGE and Glatt, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

On the production side, the report examines Pharma Continuous Granulation output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.

On the consumption side, the report analyzes sales of Pharma Continuous Granulation by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.

The report provides an overview of the global Pharma Continuous Granulation market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharma Continuous Granulation and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharma Continuous Granulation sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharma Continuous Granulation market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharma Continuous Granulation Segment by Company

LB Bohle

GEA

LCI

Chansemt

Thermo Fisher Scientific

Syntegon

Senieer

LÖDIGE

Glatt

Gericke

Pharma Continuous Granulation Segment by Type

Dry Method

Wet Method

Pharma Continuous Granulation Segment by Application

Tablets

Capsules

Others

Pharma Continuous Granulation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Continuous Granulation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharma Continuous Granulation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Continuous Granulation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharma Continuous Granulation market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharma Continuous Granulation industry.

Chapter 3: Detailed analysis of Pharma Continuous Granulation market competition landscape. Including Pharma Continuous Granulation manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 7: Production/Production Value of Pharma Continuous Granulation by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 8: Consumption of Pharma Continuous Granulation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Pharma Continuous Granulation Industry Trends Table 2. Pharma Continuous Granulation Industry Drivers Table 3. Pharma Continuous Granulation Industry Opportunities and Challenges Table 4. Pharma Continuous Granulation Industry Restraints Table 5. Global Pharma Continuous Granulation Production Value by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pharma Continuous Granulation Production Value Share by Manufacturers (2021-2026) Table 7. Global Pharma Continuous Granulation Production by Manufacturers (K Units) & (2021-2026) Table 8. Global Pharma Continuous Granulation Production Market Share by Manufacturers Table 9. Global Pharma Continuous Granulation Average Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Pharma Continuous Granulation Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pharma Continuous Granulation Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pharma Continuous Granulation Manufacturers, Product Type & Application Table 13. Global Pharma Continuous Granulation Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharma Continuous Granulation by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Major Manufacturers of Dry Method Table 17. Major Manufacturers of Wet Method Table 18. Global Pharma Continuous Granulation Production by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Pharma Continuous Granulation Production by Type (2021-2026) & (K Units) Table 20. Global Pharma Continuous Granulation Production by Type (2027-2032) & (K Units) Table 21. Global Pharma Continuous Granulation Production Market Share by Type (2021-2026) Table 22. Global Pharma Continuous Granulation Production Market Share by Type (2027-2032) Table 23. Global Pharma Continuous Granulation Production Value by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Pharma Continuous Granulation Production Value by Type (2021-2026) & (K Units) Table 25. Global Pharma Continuous Granulation Production Value by Type (2027-2032) & (K Units) Table 26. Global Pharma Continuous Granulation Production Value Market Share by Type (2021-2026) Table 27. Global Pharma Continuous Granulation Production Value Market Share by Type (2027-2032) Table 28. Major Manufacturers of Tablets Table 29. Major Manufacturers of Capsules Table 30. Major Manufacturers of Others Table 31. Global Pharma Continuous Granulation Production by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Pharma Continuous Granulation Production by Application (2021-2026) & (K Units) Table 33. Global Pharma Continuous Granulation Production by Application (2027-2032) & (K Units) Table 34. Global Pharma Continuous Granulation Production Market Share by Application (2021-2026) Table 35. Global Pharma Continuous Granulation Production Market Share by Application (2027-2032) Table 36. Global Pharma Continuous Granulation Production Value by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Pharma Continuous Granulation Production Value by Application (2021-2026) & (K Units) Table 38. Global Pharma Continuous Granulation Production Value by Application (2027-2032) & (K Units) Table 39. Global Pharma Continuous Granulation Production Value Market Share by Application (2021-2026) Table 40. Global Pharma Continuous Granulation Production Value Market Share by Application (2027-2032) Table 41. LB Bohle Company Information Table 42. LB Bohle Business Overview Table 43. LB Bohle Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 44. LB Bohle Pharma Continuous Granulation Product Portfolio Table 45. LB Bohle Recent Development Table 46. GEA Company Information Table 47. GEA Business Overview Table 48. GEA Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. GEA Pharma Continuous Granulation Product Portfolio Table 50. GEA Recent Development Table 51. LCI Company Information Table 52. LCI Business Overview Table 53. LCI Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 54. LCI Pharma Continuous Granulation Product Portfolio Table 55. LCI Recent Development Table 56. Chansemt Company Information Table 57. Chansemt Business Overview Table 58. Chansemt Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Chansemt Pharma Continuous Granulation Product Portfolio Table 60. Chansemt Recent Development Table 61. Thermo Fisher Scientific Company Information Table 62. Thermo Fisher Scientific Business Overview Table 63. Thermo Fisher Scientific Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Thermo Fisher Scientific Pharma Continuous Granulation Product Portfolio Table 65. Thermo Fisher Scientific Recent Development Table 66. Syntegon Company Information Table 67. Syntegon Business Overview Table 68. Syntegon Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Syntegon Pharma Continuous Granulation Product Portfolio Table 70. Syntegon Recent Development Table 71. Senieer Company Information Table 72. Senieer Business Overview Table 73. Senieer Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Senieer Pharma Continuous Granulation Product Portfolio Table 75. Senieer Recent Development Table 76. LÖDIGE Company Information Table 77. LÖDIGE Business Overview Table 78. LÖDIGE Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. LÖDIGE Pharma Continuous Granulation Product Portfolio Table 80. LÖDIGE Recent Development Table 81. Glatt Company Information Table 82. Glatt Business Overview Table 83. Glatt Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Glatt Pharma Continuous Granulation Product Portfolio Table 85. Glatt Recent Development Table 86. Gericke Company Information Table 87. Gericke Business Overview Table 88. Gericke Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Gericke Pharma Continuous Granulation Product Portfolio Table 90. Gericke Recent Development Table 91. Global Pharma Continuous Granulation Production by Region: 2021 VS 2025 VS 2032 (K Units) Table 92. Global Pharma Continuous Granulation Production by Region (2021-2026) & (K Units) Table 93. Global Pharma Continuous Granulation Production Market Share by Region (2021-2026) Table 94. Global Pharma Continuous Granulation Production Forecast by Region (2027-2032) & (K Units) Table 95. Global Pharma Continuous Granulation Production Market Share Forecast by Region (2027-2032) Table 96. Global Pharma Continuous Granulation Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 97. Global Pharma Continuous Granulation Production Value by Region (2021-2026) & (US$ Million) Table 98. Global Pharma Continuous Granulation Production Value Share by Region (2021-2026) Table 99. Global Pharma Continuous Granulation Production Value by Region (2027-2032) & (US$ Million) Table 100. Global Pharma Continuous Granulation Production Value Share by Region: (2027-2032) & (US$ Million) Table 101. Global Pharma Continuous Granulation Market Average Price (US$/Unit) by Region (2021-2026) Table 102. Global Pharma Continuous Granulation Market Average Price (US$/Unit) by Region (2027-2032) Table 103. Global Pharma Continuous Granulation Consumption by Region: 2021 VS 2025 VS 2032 (K Units) Table 104. Global Pharma Continuous Granulation Consumption by Region (2021-2026) & (K Units) Table 105. Global Pharma Continuous Granulation Consumption Market Share by Region (2021-2026) Table 106. Global Pharma Continuous Granulation Consumption Forecasted by Region (2027-2032) & (K Units) Table 107. Global Pharma Continuous Granulation Consumption Forecasted Market Share by Region (2027-2032) Table 108. North America Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 109. North America Pharma Continuous Granulation Consumption by Country (2021-2026) & (K Units) Table 110. North America Pharma Continuous Granulation Consumption by Country (2027-2032) & (K Units) Table 111. Europe Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 112. Europe Pharma Continuous Granulation Consumption by Country (2021-2026) & (K Units) Table 113. Europe Pharma Continuous Granulation Consumption by Country (2027-2032) & (K Units) Table 114. Asia Pacific Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 115. Asia Pacific Pharma Continuous Granulation Consumption by Country (2021-2026) & (K Units) Table 116. Asia Pacific Pharma Continuous Granulation Consumption by Country (2027-2032) & (K Units) Table 117. South America Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 118. South America Pharma Continuous Granulation Consumption by Country (2021-2026) & (K Units) Table 119. South America Pharma Continuous Granulation Consumption by Country (2027-2032) & (K Units) Table 120. Middle East & Africa Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 121. Middle East & Africa Pharma Continuous Granulation Consumption by Country (2021-2026) & (K Units) Table 122. Middle East & Africa Pharma Continuous Granulation Consumption by Country (2027-2032) & (K Units) Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Pharma Continuous Granulation Distributors List Table 126. Pharma Continuous Granulation Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Pharma Continuous Granulation Product Image Figure 2. Global Pharma Continuous Granulation Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharma Continuous Granulation Production Value (2021-2032) & (US$ Million) Figure 4. Global Pharma Continuous Granulation Production Capacity (2021-2032) & (K Units) Figure 5. Global Pharma Continuous Granulation Production (2021-2032) & (K Units) Figure 6. Global Pharma Continuous Granulation Average Price (US$/Unit) & (2021-2032) Figure 7. Global Top 5 and 10 Pharma Continuous Granulation Players Market Share by Production Value in 2025 Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Dry Method Image Figure 10. Wet Method Image Figure 11. Global Pharma Continuous Granulation Production by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Pharma Continuous Granulation Production Market Share 2021 VS 2025 VS 2032 Figure 13. Global Pharma Continuous Granulation Production Market Share by Type (2021-2032) Figure 14. Global Pharma Continuous Granulation Production Value by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Pharma Continuous Granulation Production Value Share 2021 VS 2025 VS 2032 Figure 16. Global Pharma Continuous Granulation Production Value Share by Type (2021-2032) Figure 17. Tablets Image Figure 18. Capsules Image Figure 19. Others Image Figure 20. Global Pharma Continuous Granulation Production by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Pharma Continuous Granulation Production Market Share 2021 VS 2025 VS 2032 Figure 22. Global Pharma Continuous Granulation Production Market Share by Application (2021-2032) Figure 23. Global Pharma Continuous Granulation Production Value by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Pharma Continuous Granulation Production Value Share 2021 VS 2025 VS 2032 Figure 25. Global Pharma Continuous Granulation Production Value Share by Application (2021-2032) Figure 26. Global Pharma Continuous Granulation Production by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Pharma Continuous Granulation Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Pharma Continuous Granulation Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Pharma Continuous Granulation Production Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Pharma Continuous Granulation Production Value (2021-2032) & (US$ Million) Figure 31. Europe Pharma Continuous Granulation Production Value (2021-2032) & (US$ Million) Figure 32. Asia-Pacific Pharma Continuous Granulation Production Value (2021-2032) & (US$ Million) Figure 33. South America Pharma Continuous Granulation Production Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Pharma Continuous Granulation Production Value (2021-2032) & (US$ Million) Figure 35. North America Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 36. North America Pharma Continuous Granulation Consumption Market Share by Country (2021-2032) Figure 37. U.S. Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 38. Canada Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 39. Mexico Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 40. Europe Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 41. Europe Pharma Continuous Granulation Consumption Market Share by Country (2021-2032) Figure 42. Germany Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 43. France Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 44. U.K. Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 45. Italy Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 46. Netherlands Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 47. Asia Pacific Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 48. Asia Pacific Pharma Continuous Granulation Consumption Market Share by Country (2021-2032) Figure 49. China Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 50. Japan Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 51. South Korea Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 52. Southeast Asia Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 53. India Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 54. Australia Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 55. South America Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 56. South America Pharma Continuous Granulation Consumption Market Share by Country (2021-2032) Figure 57. Brazil Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 58. Argentina Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 60. Middle East & Africa Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 61. Middle East & Africa Pharma Continuous Granulation Consumption Market Share by Country (2021-2032) Figure 62. Egypt Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 63. South Africa Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 64. Israel Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 65. Türkiye Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 66. GCC Countries Pharma Continuous Granulation Consumption and Growth Rate (2021-2032) & (K Units) Figure 67. Pharma Continuous Granulation Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Pharma Continuous Granulation Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Dry Method
  • Wet Method
Applications
  • Tablets
  • Capsules
  • Others
Companies covered
  • LB Bohle
  • GEA
  • LCI
  • Chansemt
  • Thermo Fisher Scientific
  • Syntegon
  • Senieer
  • LÖDIGE
  • Glatt
  • Gericke

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pharma Continuous Granulation Production Value Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pharma Continuous Granulation Production Capacity Estimates and Forecasts (2021-2032)
  5. 1.2.3 Global Pharma Continuous Granulation Production Estimates and Forecasts (2021-2032)
  6. 1.2.4 Global Pharma Continuous Granulation Market Average Price (2021-2032)
  7. 1.3 Assumptions and Limitations
  8. 1.4 Study Goals and Objectives
2 Global Pharma Continuous Granulation Market Dynamics
  1. 2.1 Pharma Continuous Granulation Industry Trends
  2. 2.2 Pharma Continuous Granulation Industry Drivers
  3. 2.3 Pharma Continuous Granulation Industry Opportunities and Challenges
  4. 2.4 Pharma Continuous Granulation Industry Restraints
3 Pharma Continuous Granulation Market by Manufacturers
  1. 3.1 Global Pharma Continuous Granulation Production Value by Manufacturers (2021-2026)
  2. 3.2 Global Pharma Continuous Granulation Production by Manufacturers (2021-2026)
  3. 3.3 Global Pharma Continuous Granulation Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Pharma Continuous Granulation Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pharma Continuous Granulation Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pharma Continuous Granulation Manufacturers, Product Type & Application
  7. 3.7 Global Pharma Continuous Granulation Manufacturers Established Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pharma Continuous Granulation Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pharma Continuous Granulation Players Market Share by Production Value in 2025
  11. 3.8.3 2025 Pharma Continuous Granulation Tier 1, Tier 2, and Tier 3
4 Pharma Continuous Granulation Market by Type
  1. 4.1 Pharma Continuous Granulation Type Introduction
  2. 4.1.1 Dry Method
  3. 4.1.2 Wet Method
  4. 4.2 Global Pharma Continuous Granulation Production by Type
  5. 4.2.1 Global Pharma Continuous Granulation Production by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pharma Continuous Granulation Production by Type (2021-2032)
  7. 4.2.3 Global Pharma Continuous Granulation Production Market Share by Type (2021-2032)
  8. 4.3 Global Pharma Continuous Granulation Production Value by Type
  9. 4.3.1 Global Pharma Continuous Granulation Production Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pharma Continuous Granulation Production Value by Type (2021-2032)
  11. 4.3.3 Global Pharma Continuous Granulation Production Value Market Share by Type (2021-2032)
5 Pharma Continuous Granulation Market by Application
  1. 5.1 Pharma Continuous Granulation Application Introduction
  2. 5.1.1 Tablets
  3. 5.1.2 Capsules
  4. 5.1.3 Others
  5. 5.2 Global Pharma Continuous Granulation Production by Application
  6. 5.2.1 Global Pharma Continuous Granulation Production by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharma Continuous Granulation Production by Application (2021-2032)
  8. 5.2.3 Global Pharma Continuous Granulation Production Market Share by Application (2021-2032)
  9. 5.3 Global Pharma Continuous Granulation Production Value by Application
  10. 5.3.1 Global Pharma Continuous Granulation Production Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pharma Continuous Granulation Production Value by Application (2021-2032)
  12. 5.3.3 Global Pharma Continuous Granulation Production Value Market Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 LB Bohle
  2. 6.1.1 LB Bohle Company Information
  3. 6.1.2 LB Bohle Business Overview
  4. 6.1.3 LB Bohle Pharma Continuous Granulation Production, Value and Gross Margin (2021-2026)
  5. 6.1.4 LB Bohle Pharma Continuous Granulation Product Portfolio
  6. 6.1.5 LB Bohle Recent Developments
  7. 6.2 GEA
  8. 6.2.1 GEA Company Information
  9. 6.2.2 GEA Business Overview
  10. 6.2.3 GEA Pharma Continuous Granulation Production, Value and Gross Margin (2021-2026)
  11. 6.2.4 GEA Pharma Continuous Granulation Product Portfolio
  12. 6.2.5 GEA Recent Developments
  13. 6.3 LCI
  14. 6.3.1 LCI Company Information
  15. 6.3.2 LCI Business Overview
  16. 6.3.3 LCI Pharma Continuous Granulation Production, Value and Gross Margin (2021-2026)
  17. 6.3.4 LCI Pharma Continuous Granulation Product Portfolio
  18. 6.3.5 LCI Recent Developments
  19. 6.4 Chansemt
  20. 6.4.1 Chansemt Company Information
  21. 6.4.2 Chansemt Business Overview
  22. 6.4.3 Chansemt Pharma Continuous Granulation Production, Value and Gross Margin (2021-2026)
  23. 6.4.4 Chansemt Pharma Continuous Granulation Product Portfolio
  24. 6.4.5 Chansemt Recent Developments
  25. 6.5 Thermo Fisher Scientific
  26. 6.5.1 Thermo Fisher Scientific Company Information
  27. 6.5.2 Thermo Fisher Scientific Business Overview
  28. 6.5.3 Thermo Fisher Scientific Pharma Continuous Granulation Production, Value and Gross Margin (2021-2026)
  29. 6.5.4 Thermo Fisher Scientific Pharma Continuous Granulation Product Portfolio
  30. 6.5.5 Thermo Fisher Scientific Recent Developments
  31. 6.6 Syntegon
  32. 6.6.1 Syntegon Company Information
  33. 6.6.2 Syntegon Business Overview
  34. 6.6.3 Syntegon Pharma Continuous Granulation Production, Value and Gross Margin (2021-2026)
  35. 6.6.4 Syntegon Pharma Continuous Granulation Product Portfolio
  36. 6.6.5 Syntegon Recent Developments
  37. 6.7 Senieer
  38. 6.7.1 Senieer Company Information
  39. 6.7.2 Senieer Business Overview
  40. 6.7.3 Senieer Pharma Continuous Granulation Production, Value and Gross Margin (2021-2026)
  41. 6.7.4 Senieer Pharma Continuous Granulation Product Portfolio
  42. 6.7.5 Senieer Recent Developments
  43. 6.8 LÖDIGE
  44. 6.8.1 LÖDIGE Company Information
  45. 6.8.2 LÖDIGE Business Overview
  46. 6.8.3 LÖDIGE Pharma Continuous Granulation Production, Value and Gross Margin (2021-2026)
  47. 6.8.4 LÖDIGE Pharma Continuous Granulation Product Portfolio
  48. 6.8.5 LÖDIGE Recent Developments
  49. 6.9 Glatt
  50. 6.9.1 Glatt Company Information
  51. 6.9.2 Glatt Business Overview
  52. 6.9.3 Glatt Pharma Continuous Granulation Production, Value and Gross Margin (2021-2026)
  53. 6.9.4 Glatt Pharma Continuous Granulation Product Portfolio
  54. 6.9.5 Glatt Recent Developments
  55. 6.10 Gericke
  56. 6.10.1 Gericke Company Information
  57. 6.10.2 Gericke Business Overview
  58. 6.10.3 Gericke Pharma Continuous Granulation Production, Value and Gross Margin (2021-2026)
  59. 6.10.4 Gericke Pharma Continuous Granulation Product Portfolio
  60. 6.10.5 Gericke Recent Developments
7 Global Pharma Continuous Granulation Production by Region
  1. 7.1 Global Pharma Continuous Granulation Production by Region: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharma Continuous Granulation Production by Region (2021-2032)
  3. 7.2.1 Global Pharma Continuous Granulation Production by Region (2021-2026)
  4. 7.2.2 Global Pharma Continuous Granulation Production Forecast by Region (2027-2032)
  5. 7.3 Global Pharma Continuous Granulation Production by Region: 2021 VS 2025 VS 2032
  6. 7.4 Global Pharma Continuous Granulation Production Value by Region (2021-2032)
  7. 7.4.1 Global Pharma Continuous Granulation Production Value by Region (2021-2026)
  8. 7.4.2 Global Pharma Continuous Granulation Production Value by Region (2027-2032)
  9. 7.5 Global Pharma Continuous Granulation Market Price Analysis by Region (2021-2032)
  10. 7.6 Regional Production Value Trends (2021-2032)
  11. 7.6.1 North America Pharma Continuous Granulation Production Value (2021-2032)
  12. 7.6.2 Europe Pharma Continuous Granulation Production Value (2021-2032)
  13. 7.6.3 Asia-Pacific Pharma Continuous Granulation Production Value (2021-2032)
  14. 7.6.4 South America Pharma Continuous Granulation Production Value (2021-2032)
  15. 7.6.5 Middle East & Africa Pharma Continuous Granulation Production Value (2021-2032)
8 Global Pharma Continuous Granulation Consumption by Region
  1. 8.1 Global Pharma Continuous Granulation Consumption by Region: 2021 VS 2025 VS 2032
  2. 8.2 Global Pharma Continuous Granulation Consumption by Region (2021-2032)
  3. 8.2.1 Global Pharma Continuous Granulation Consumption by Region (2021-2026)
  4. 8.2.2 Global Pharma Continuous Granulation Consumption by Region (2027-2032)
  5. 8.3 North America
  6. 8.3.1 North America Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 8.3.2 North America Pharma Continuous Granulation Consumption by Country (2021-2032)
  8. 8.3.3 U.S.
  9. 8.3.4 Canada
  10. 8.3.5 Mexico
  11. 8.4 Europe
  12. 8.4.1 Europe Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 8.4.2 Europe Pharma Continuous Granulation Consumption by Country (2021-2032)
  14. 8.4.3 Germany
  15. 8.4.4 France
  16. 8.4.5 U.K.
  17. 8.4.6 Italy
  18. 8.4.7 Netherlands
  19. 8.5 Asia Pacific
  20. 8.5.1 Asia Pacific Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 8.5.2 Asia Pacific Pharma Continuous Granulation Consumption by Country (2021-2032)
  22. 8.5.3 China
  23. 8.5.4 Japan
  24. 8.5.5 South Korea
  25. 8.5.6 Southeast Asia
  26. 8.5.7 India
  27. 8.5.8 Australia
  28. 8.6 South America
  29. 8.6.1 South America Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 8.6.2 South America Pharma Continuous Granulation Consumption by Country (2021-2032)
  31. 8.6.3 Brazil
  32. 8.6.4 Argentina
  33. 8.6.5 Chile
  34. 8.6.6 Colombia
  35. 8.7 Middle East & Africa
  36. 8.7.1 Middle East & Africa Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  37. 8.7.2 Middle East & Africa Pharma Continuous Granulation Consumption by Country (2021-2032)
  38. 8.7.3 Egypt
  39. 8.7.4 South Africa
  40. 8.7.5 Israel
  41. 8.7.6 Türkiye
  42. 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharma Continuous Granulation Value Chain Analysis
  2. 9.1.1 Pharma Continuous Granulation Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharma Continuous Granulation Production Mode & Process
  6. 9.2 Pharma Continuous Granulation Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharma Continuous Granulation Distributors
  9. 9.2.3 Pharma Continuous Granulation Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst